Search Results - "Gomaa, Mokhtar R"
-
1
Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies
Published in Scientific reports (28-07-2022)“…During the current coronavirus disease 2019 (COVID-19) pandemic, symptoms of depression are commonly documented among both symptomatic and asymptomatic…”
Get full text
Journal Article -
2
EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2
Published in PloS one (18-11-2020)“…Due to the challenges for developing vaccines in devastating pandemic situations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), developing…”
Get full text
Journal Article -
3
FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
Published in Pharmaceuticals (Basel, Switzerland) (04-12-2020)“…(1) Background: Drug repositioning is an unconventional drug discovery approach to explore new therapeutic benefits of existing drugs. Currently, it emerges as…”
Get full text
Journal Article -
4
Avian Influenza A(H5N1) and A(H9N2) Seroprevalence and Risk Factors for Infection Among Egyptians: A Prospective, Controlled Seroepidemiological Study
Published in The Journal of infectious diseases (01-05-2015)“…A(H5N1) and A(H9N2) avian influenza viruses are enzootic in Egyptian poultry, and most A (H5N1) human cases since 2009 have occurred in Egypt. Our…”
Get full text
Journal Article -
5
Incidence and Seroprevalence of Avian Influenza in a Cohort of Backyard Poultry Growers, Egypt, August 2015-March 2019
Published in Emerging infectious diseases (01-09-2020)“…Currently enzootic avian influenza H5N1, H9N2, and H5N8 viruses were introduced into poultry in Egypt in 2006, 2011, and 2016, respectively. Infections with…”
Get full text
Journal Article -
6
Sinapic Acid Suppresses SARS CoV-2 Replication by Targeting Its Envelope Protein
Published in Antibiotics (Basel) (11-04-2021)“…SARS CoV-2 is still considered a global health issue, and its threat keeps growing with the emergence of newly evolved strains. Despite the success in…”
Get full text
Journal Article -
7
Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2
Published in PloS one (28-10-2020)“…Anecdotal evidence showed a negative correlation between Bacille Calmette-Guérin (BCG) vaccination and incidence of COVID-19. Incidence of the disease in…”
Get full text
Journal Article -
8
Middle East respiratory syndrome coronavirus: a comprehensive review
Published in Frontiers of medicine (01-06-2016)“…The Middle East respiratory syndrome eoronavirus was first identified in 2012 and has since then remained uncontrolled. Cases have been mostly reported in the…”
Get full text
Journal Article -
9
SARS-CoV-2 Genetic Diversity and Lineage Dynamics in Egypt during the First 18 Months of the Pandemic
Published in Viruses (25-08-2022)“…COVID-19 was first diagnosed in Egypt on 14 February 2020. By the end of November 2021, over 333,840 cases and 18,832 deaths had been reported. As part of the…”
Get full text
Journal Article -
10
Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E
Published in Microorganisms (Basel) (01-11-2023)“…Repurposing vitamins as antiviral supporting agents is a rapid approach used to control emerging viral infections. Although there is considerable evidence…”
Get full text
Journal Article -
11
Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt
Published in Emerging microbes & infections (01-01-2017)“…Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe human infections and dromedary camels are considered an intermediary host. The dynamics…”
Get full text
Journal Article -
12
Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in Egyptian Convalescent Plasma Donors
Published in Frontiers in microbiology (24-11-2020)“…Using convalescent plasma as immunotherapy is an old method for treatment of infectious diseases. Several countries have recently allowed the use of such…”
Get full text
Journal Article -
13
Surveillance for Coronaviruses in Bats, Lebanon and Egypt, 2013-2015
Published in Emerging infectious diseases (01-01-2016)Get full text
Journal Article -
14
Serological Evidence of Human Infection with Avian Influenza A H7virus in Egyptian Poultry Growers
Published in PloS one (03-06-2016)“…Avian influenza viruses circulate widely in birds, with occasional human infections. Poultry-exposed individuals are considered to be at high risk of infection…”
Get full text
Journal Article -
15
Complete Genome Sequence of Middle East Respiratory Syndrome Coronavirus Isolated from a Dromedary Camel in Egypt
Published in Genome announcements (Washington, DC) (28-04-2016)“…We generated the near-full genome sequence of Middle East respiratory syndrome coronavirus (MERS-CoV) from a collected nasal sample of dromedary camel in…”
Get full text
Journal Article -
16
Induced humoral immunity of different types of vaccines against most common variants of SARS-CoV-2 in Egypt prior to Omicron outbreak
Published in Vaccine (30-07-2022)“…The diversity of SARS-CoV-2 continues to lead to the emergence of new SARS-CoV-2 variants. SARS-CoV-2 antibody assays are crucial in managing the COVID-19…”
Get full text
Journal Article -
17
Isolation and Characterization of a Distinct Influenza A Virus from Egyptian Bats
Published in Journal of virology (15-01-2019)“…Recently, two genetically distinct influenza viruses were detected in bats in Guatemala and Peru. We conducted influenza A virus surveillance among four bat…”
Get full text
Journal Article -
18
Prevalence and determinants of SARS-CoV-2 neutralizing antibodies in Lebanon
Published in Archives of virology (01-07-2022)“…According to the Lebanese Ministry of Public Health, more than 1,053,000 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have…”
Get full text
Journal Article -
19
Delineating a potent antiviral activity of Cuphea ignea extract loaded nano-formulation against SARS-CoV-2: In silico and in vitro studies
Published in Journal of drug delivery science and technology (01-12-2021)“…The outbreak of coronavirus disease-2019, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a worldwide emerging crisis. Polyphenols…”
Get full text
Journal Article -
20
Antiviral activity of chitosan nanoparticles encapsulating silymarin (Sil-CNPs) against SARS-CoV-2 ( and study)
Published in RSC advances (23-05-2022)“…To develop a specific treatment against COVID-19, we investigated silymarin-chitosan nanoparticles (Sil-CNPs) as an antiviral agent against SARS-CoV-2 using in…”
Get full text
Journal Article